Chunbai Zhang1, Yanping Li, Atul Malhotra, Yi Ning, Xiang Gao. 1. From The Channing Division of Network Medicine (C.Z., Y.L., X.G.) and Division of Sleep Medicine (C.Z., A.M.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; the Department of Epidemiology and Community Health (Y.N.), Virginia Commonwealth University, Richmond; the Department of Nutrition (X.G.), Harvard School of Public Health, Boston, MA; and School of Public Health (XG), Peking Union Medical College, Beijing, China.
Abstract
OBJECTIVE: To examine the potential long-term impact of restless legs syndrome (RLS) and other common sleep complaints on subsequent physical function (PF), we conducted a longitudinal analysis of 12,556 men in the Health Professionals Follow-up Study. METHODS: We used a set of questions recommended by the International RLS Study Group to assess RLS in 2002. We asked questions regarding other sleep complaints--insomnia, sleep fragmentation, and excessive daytime sleepiness--in 2004. We used the Physical Function (PF-10) survey of the Short Form-36 Health Survey to characterize PF in 1996 and 2008. We examined the 2008 PF-10 scores across categories of baseline RLS (2002), adjusted for age, 1996 PF-10 score, and other potential confounders. RESULTS: The participants with RLS at baseline had significantly lower PF-10 score 6 years later than those without RLS (mean difference = -2.32, p = 0.01), after adjusting for potential confounders. The magnitude of difference in PF-10 score for RLS symptoms ≥ 15 times/month vs no RLS was more than that of a 5-year increase of age or moderate amount of smoking. Having daily daytime sleepiness and sleep duration ≥ 9 hours/day were associated with lower mean PF value than not having these symptoms (p < 0.05 for both). CONCLUSIONS: RLS and other sleep complaints are associated with lower PF. Our findings need to be replicated by more longitudinal studies including women and populations of other social and cultural backgrounds. It is important to understand whether RLS is an independent risk factor or a marker for other unknown risk factors for disability.
OBJECTIVE: To examine the potential long-term impact of restless legs syndrome (RLS) and other common sleep complaints on subsequent physical function (PF), we conducted a longitudinal analysis of 12,556 men in the Health Professionals Follow-up Study. METHODS: We used a set of questions recommended by the International RLS Study Group to assess RLS in 2002. We asked questions regarding other sleep complaints--insomnia, sleep fragmentation, and excessive daytime sleepiness--in 2004. We used the Physical Function (PF-10) survey of the Short Form-36 Health Survey to characterize PF in 1996 and 2008. We examined the 2008 PF-10 scores across categories of baseline RLS (2002), adjusted for age, 1996 PF-10 score, and other potential confounders. RESULTS: The participants with RLS at baseline had significantly lower PF-10 score 6 years later than those without RLS (mean difference = -2.32, p = 0.01), after adjusting for potential confounders. The magnitude of difference in PF-10 score for RLS symptoms ≥ 15 times/month vs no RLS was more than that of a 5-year increase of age or moderate amount of smoking. Having daily daytime sleepiness and sleep duration ≥ 9 hours/day were associated with lower mean PF value than not having these symptoms (p < 0.05 for both). CONCLUSIONS: RLS and other sleep complaints are associated with lower PF. Our findings need to be replicated by more longitudinal studies including women and populations of other social and cultural backgrounds. It is important to understand whether RLS is an independent risk factor or a marker for other unknown risk factors for disability.
Authors: Louise McCrink; Richard P Allen; Sorrel Wolowacz; Beth Sherrill; Mark Connolly; Jeff Kirsch Journal: Sleep Med Date: 2006-10-04 Impact factor: 3.492
Authors: Patricia A Boyle; Aron S Buchman; Robert S Wilson; Julia L Bienias; David A Bennett Journal: J Am Geriatr Soc Date: 2007-02 Impact factor: 5.562
Authors: Xiang Gao; Honglei Chen; Michael A Schwarzschild; Dale B Glasser; Giancarlo Logroscino; Eric B Rimm; Alberto Ascherio Journal: Am J Epidemiol Date: 2007-09-17 Impact factor: 4.897
Authors: Wolfgang H Oertel; Yngve Hallström; Gerda M Saletu-Zyhlarz; Michael Hopp; Björn Bosse; Claudia Trenkwalder Journal: CNS Drugs Date: 2016-08 Impact factor: 5.749
Authors: Esther Cubo; Cesar Gallego-Nieto; Miren Elizari-Roncal; Teresa Barroso-Pérez; Carla Collazo; Sara Calvo; Pedro David Delgado-López Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2019-07-19
Authors: Malik Nassan; Iyas Daghlas; John W Winkelman; Hassan S Dashti; Richa Saxena Journal: Neuropsychopharmacology Date: 2022-05-10 Impact factor: 8.294
Authors: Sergio Garbarino; Paola Lanteri; Paolo Durando; Nicola Magnavita; Walter G Sannita Journal: Int J Environ Res Public Health Date: 2016-08-18 Impact factor: 3.390
Authors: Yinge Li; Yanping Li; John W Winkelman; Arthur S Walters; Jiali Han; Frank B Hu; Xiang Gao Journal: Neurology Date: 2017-12-15 Impact factor: 9.910